News Feed
Events By OncoDaily
OncoGrants
OncoDaily TV
NewsLetter
Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
Career Updates
Oncology Drugs
Dialogues
Stories

Celebrities and Cancer
Immune Oncology
Breast Oncology
Gastrointestinal Oncology
Genitourinary Oncology
Lung Oncology
Hematology
Radiotherapy
Cancer Types
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Oncologist Near Me

Childhood Cancer
Health Policy
Hall of Fame
OncoIndustry
Public Health
Oncology Tech
Blog Posts
Global Cancer Movement
History
Oncolibrary
OncoThon 2025

Global Hubs
OncoDaily India
OncoDaily Brazil
OncoDaily Algeria
OncoDaily Kenya

Yvonne Awards
OncoDaily Party
How I Treat
O Series
Global Oncothon

OncoDaily Medical Journal
OncoDaily Newsletters
OncoDaily Magazine
CancerWorld Magazine
World Health Magazine
BIGR
Hemostasis Today
Fertility News

OncoDaily GI
OncoDaily Breast
OncoDaily IO
OncoDaily Lung
OncoDaily RT
OncoDaily GU
OncoDaily AI
OncoDaily Biotech
Hematology

Services
Partners
Contact us
About OncoDaily
P53 Inc
Privacy Policy
Editorial Policy
Disclaimer
Cookie Policy

Oct / 2026

October 2026
M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

« Sep

Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
Career Updates
Oncology Drugs
Dialogues
Stories

News Feed
Events By OncoDaily
OncoGrants
OncoDaily TV
NewsLetter

OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

MAMMÔ 2026: Global Breast Cancer Virtual Congress

Armenia Becomes First Country to Approve Agenus’ BOT+BAL for MSS Metastatic Colorectal Cancer

20 Posts Not To Miss From GCOS 2026

Datopotamab Deruxtecan Approved in China for Advanced Triple-Negative Breast Cancer

10 Bladder and Urothelial Cancer Trials to Watch at ESMO 2026

Christian Ntizimira Named Candidate for UICC Board of Directors 2026–2028

Sushmita Sen: Advancing Open and Inclusive HTA in Cancer Drug Development

Quality of Life After Chemoradiotherapy in Anal Cancer

message

Oct 12, 2024 11:00 am

Blog Posts

SIOP Europe – A Virtual Awareness Wall dedicated to inspiring the paediatric oncology community

Headlines

ASCOT 5-Year Follow-Up: Adjuvant S-1 After Resection for BTC

Oct 12, 2024

Nivolumab/Ipilimumab and Pembrolizumab for All Cancers: Australia Expands Immunotherapy Access

Oct 12, 2024

Bayer Plans $2.2 Billion Ohio Manufacturing Campus to Support Oncology and Cardiorenal Portfolio

Oct 12, 2024

Brazil Unlocked: Jennifer S. Buell on Brazil’s Role in Advancing Agenus and MiNK Therapeutics Clinical Programs

Oct 12, 2024

20 Posts Not To Miss From IGCS 2026

Oct 12, 2024

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

OncoDaily Oncology cancer Breast Cancer cancer care ASCO Lung cancer Cancer research fight against cancer Global fight against cancer Headlines immunotherapy ESMO cancer treatment NSCLC clinical trials MD Anderson Cancer Center colorectal cancer cancer awareness prostate cancer FDA Childhood Cancer UICC Research AACR ASCO24 chemotherapy Pancreatic Cancer radiation oncology Precision Oncology Dana-Farber Cancer Institute AI WHO SIOP Robert Orlowski American Cancer Society American Society of Clinical Oncology NCI radiotherapy National Cancer Institute European Cancer Organisation cervical cancer Myeloma Paper of the Day IASLC Myeloma Paolo Tarantino Vivek Subbiah bladder cancer multiple myeloma Memorial Sloan Kettering Cancer Center

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}